Microsomal epoxide hydrolase deletion enhances tyrosine hydroxylase phosphorylation in mice after MPTP treatment.

Microsomal epoxide hydrolase deletion enhances tyrosine hydroxylase phosphorylation in mice after MPTP treatment. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Microsomal epoxide hydrolase deletion enhances tyrosine hydroxylase phosphorylation in mice after MPTP treatment. Abstract Text:

Parkinson's disease (PD) is the most prevalent neurodegenerative movement disorder. Epidemiological studies have suggested most cases of PD are linked to environmental risk factors. Microsomal epoxide hydrolase (mEH) is a conserved enzyme that catalyzes hydrolysis of a large number of epoxide intermediates such as drugs and epoxides of environmental toxins. We hypothesize that changes in mEH are involved in the pathogenesis of PD by modulating the vulnerability of dopaminergic neurons to environmental stress. Herein we reported that acute treatment with the neurotoxin MPTP (1-methyl-4-phemyl-1,2,3,6-tetrahydropyridine) markedly increased the mEH immunoreactivity in the nigrostriatal system of C57BL/6 mice. Next, mEH knockout (KO) mice were used, and we found that tyrosine hydroxylase (TH)-positive cell loss was significantly lower in the substantia nigra of mEH KO mice compared with wild-type (WT) mice after MPTP treatment. The mean dopamine turnover ratios were significantly increased in MPTP-treated mEH KO mice compared with WT. In addition, TH is the rate-limiting enzyme for dopamine biosynthesis, and its activity is mainly regulated by TH phosphorylation at Ser-31 (pSer31) and Ser-40 (pSer40). Double immunofluorescence showed that both pSer31 and pSer40 are completely colocalized in total TH-positive cells. However, immunoblotting confirmed that there was a significantly higher level of pSer31 in mEH-KO mice when compared with WT mice after MPTP, and no marked differences among TH and its phosphorylation levels occurred after saline injection. These data suggested that mEH deficiency facilitates TH phosphorylation in the nigrostriatal dopamine system, which may be associated with an increased resistance of dopaminergic neurons to environmental toxins. (c) 2008 Wiley-Liss, Inc.

Microsomal epoxide hydrolase deletion enhances tyrosine hydroxylase phosphorylation in mice after MPTP treatment. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Microsomal epoxide hydrolase deletion enhances tyrosine hydroxylase phosphorylation in mice after MPTP treatment. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of neuroscience research

VOLUME: 86

Page Numbers: 2792-801

Journal Abbreviation: J. Neurosci. Res.

ISSN: 1097-4547

DAY: 22

MONTH: Sep

YEAR: 2008

Microsomal epoxide hydrolase deletion enhances tyrosine hydroxylase phosphorylation in mice after MPTP treatment. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7600111

Microsomal epoxide hydrolase deletion enhances tyrosine hydroxylase phosphorylation in mice after MPTP treatment. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Microsomal epoxide hydrolase deletion enhances tyrosine hydroxylase phosphorylation in mice after MPTP treatment. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Microsomal epoxide hydrolase deletion enhances tyrosine hydroxylase phosphorylation in mice after MPTP treatment.

AFFILIATION: Department of Anatomy and Neurobiology, University of Kentucky, Lexington, Kentucky.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Neurosci Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Microsomal epoxide hydrolase deletion enhances tyrosine hydroxylase phosphorylation in mice after MPTP treatment Related Publications

• A device for continuous recording of concentration of Evans blue dye in whole blood and its application to determination of cardiac output.
• Beta-1-adrenoceptor agonists with low adenylate cyclase activation--theoretical and clinical implications.
• Cardiac metabolism in myocardial failure.
• Chemicals Introduced in Foods. Food and Nutrition Section. Report of the Chairman of the Committee on Chemicals Introduced in Foods.
• Complete transposition of the aorta and a levoposition of the pulmonary artery; clinical, physiological, and pathological findings.
• HIV Stigma and Social Support among African Americans.
• Improving public access to environmental information in China.
• Increasing HIV testing among latinos by bundling HIV testing with other tests.
• Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system.
• Internal carotid false aneurysm after thermocoagulation of the gasserian ganglion.
• Letter: Debrisoquine, guanethidine, and bethanidine in hypertension.
• Microsomal epoxide hydrolase deletion enhances tyrosine hydroxylase phosphorylation in mice after MPTP treatment.
• Neuroprotection with pioglitazone against LPS insult on dopaminergic neurons may be associated with its inhibition of NF-kappaB and JNK activation and suppression of COX-2 activity.
• Not Available
• Physiologic methods in the diagnosis of congenital heart disease.
• Physiological studies in congenital heart disease; the circulation in patients with isolated septal defects.
• Physiological studies in congenital heart disease; the physiological findings in two patients with complete transposition of the great vessels.
• Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/Akt.
• Protective properties afforded by pioglitazone against intrastriatal LPS in Sprague-Dawley rats.
• Pulmonary arterial hypertension in congenital heart disease.
• Rapid marked increase in plasma renin in rats treated with inhibitors of the renin system. Effects of 1-sar-8-ala-angiotensin II and of a synthetic converting enzyme inhibitor (nonapeptide, SQ 20.881) on normal and adrenalectomized rats.
• Recent studies of cardiac failure with relation to the action of digitalis.
• Relation between renin substrate and acute phase proteins. Studies of normal and adrenalectomized rats.
• Renal hyperemia after the intravenous infusion of adenylic acid adenosine, or adenosine-triphosphate in the dog.
• Species specific differences in converting enzyme and in angiotensin I.
• Structural changes and ability to release renin in auto- and allo-transplants of mouse submaxillary glands.
• The metabolism of the heart.
• The surgical treatment of mitral stenosis and its physiological consequences.
• The tissue reaction to implanted plastics.
• The value of catheterization of the heart and other physiologic procedures in the diagnosis of congenital heart disease.